251 related articles for article (PubMed ID: 6261258)
1. Identification of human eosinophil lysophospholipase as the constituent of Charcot-Leyden crystals.
Weller PF; Goetzl EJ; Austen KF
Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7440-3. PubMed ID: 6261258
[TBL] [Abstract][Full Text] [Related]
2. Biochemical characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase).
Weller PF; Bach DS; Austen KF
J Biol Chem; 1984 Dec; 259(24):15100-5. PubMed ID: 6511787
[TBL] [Abstract][Full Text] [Related]
3. Human eosinophil lysophospholipase: the sole protein component of Charcot-Leyden crystals.
Weller PF; Bach D; Austen KF
J Immunol; 1982 Mar; 128(3):1346-9. PubMed ID: 6173432
[TBL] [Abstract][Full Text] [Related]
4. Ultrastructural localization of the Charcot-Leyden crystal protein (lysophospholipase) to a distinct crystalloid-free granule population in mature human eosinophils.
Dvorak AM; Letourneau L; Login GR; Weller PF; Ackerman SJ
Blood; 1988 Jul; 72(1):150-8. PubMed ID: 2455566
[TBL] [Abstract][Full Text] [Related]
5. The Charcot-Leyden crystal protein revisited-A lysopalmitoylphospholipase and more.
Weller PF; Wang H; Melo RCN
J Leukoc Biol; 2020 Jul; 108(1):105-112. PubMed ID: 32272499
[TBL] [Abstract][Full Text] [Related]
6. Ultrastructural localization of Charcot-Leyden crystal protein (lysophospholipase) to intracytoplasmic crystals in tumor cells of primary solid and papillary epithelial neoplasm of the pancreas.
Dvorak AM; Letourneau L; Weller PF; Ackerman SJ
Lab Invest; 1990 May; 62(5):608-15. PubMed ID: 2160563
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of human Charcot-Leyden crystal protein, an eosinophil lysophospholipase, identifies it as a new member of the carbohydrate-binding family of galectins.
Leonidas DD; Elbert BL; Zhou Z; Leffler H; Ackerman SJ; Acharya KR
Structure; 1995 Dec; 3(12):1379-93. PubMed ID: 8747464
[TBL] [Abstract][Full Text] [Related]
8. The gene for human eosinophil Charcot-Leyden crystal protein directs expression of lysophospholipase activity and spontaneous crystallization in transiently transfected COS cells.
Zhou Z; Tenen DG; Dvorak AM; Ackerman SJ
J Leukoc Biol; 1992 Dec; 52(6):588-95. PubMed ID: 1464731
[TBL] [Abstract][Full Text] [Related]
9. Crystallographic characterization of human eosinophil Charcot-Leyden crystals.
Sieker LC; Turley S; Le Trong I; Stenkamp RE; Weller PF; Ackerman SJ
J Mol Biol; 1988 Nov; 204(2):489-91. PubMed ID: 3221396
[No Abstract] [Full Text] [Related]
10. Ultrastructural localization of the Charcot-Leyden crystal protein (lysophospholipase) to granules and intragranular crystals in mature human basophils.
Dvorak AM; Ackerman SJ
Lab Invest; 1989 Apr; 60(4):557-67. PubMed ID: 2709814
[TBL] [Abstract][Full Text] [Related]
11. Mature eosinophils stimulated to develop in human cord blood mononuclear cell cultures supplemented with recombinant human interleukin-5. Part I. Piecemeal degranulation of specific granules and distribution of Charcot-Leyden crystal protein.
Dvorak AM; Furitsu T; Letourneau L; Ishizaka T; Ackerman SJ
Am J Pathol; 1991 Jan; 138(1):69-82. PubMed ID: 1987770
[TBL] [Abstract][Full Text] [Related]
12. Localization of Charcot-Leyden crystal protein in individual morphological phenotypes of human basophils stimulated by f-Met peptide.
Dvorak AM; MacGlashan DW; Warner JA; Letourneau L; Morgan ES; Lichtenstein LM; Ackerman SJ
Clin Exp Allergy; 1997 Apr; 27(4):452-74. PubMed ID: 9146940
[TBL] [Abstract][Full Text] [Related]
13. Significance of Charcot Leyden crystals in liver cytology-A case report.
Thakral D; Agarwal P; Saran RK; Saluja S
Diagn Cytopathol; 2015 May; 43(5):392-4. PubMed ID: 25350873
[TBL] [Abstract][Full Text] [Related]
14. Charcot-Leyden crystals: pathology and diagnostic utility.
Pantanowitz L; Balogh K
Ear Nose Throat J; 2004 Jul; 83(7):489-90. PubMed ID: 15372922
[TBL] [Abstract][Full Text] [Related]
15. Expression of lysophospholipase activity by intact human eosinophils and their Charcot-Leyden crystals.
Weller PF; Bach D; Austen KF
Trans Assoc Am Physicians; 1981; 94():165-71. PubMed ID: 7344218
[No Abstract] [Full Text] [Related]
16. Charcot-Leyden crystal protein (galectin-10) is not a dual function galectin with lysophospholipase activity but binds a lysophospholipase inhibitor in a novel structural fashion.
Ackerman SJ; Liu L; Kwatia MA; Savage MP; Leonidas DD; Swaminathan GJ; Acharya KR
J Biol Chem; 2002 Apr; 277(17):14859-68. PubMed ID: 11834744
[TBL] [Abstract][Full Text] [Related]
17. Formation of Charcot-Leyden crystals by human basophils.
Ackerman SJ; Weil GJ; Gleich GJ
J Exp Med; 1982 Jun; 155(6):1597-609. PubMed ID: 7042896
[TBL] [Abstract][Full Text] [Related]
18. Charcot-Leyden crystal protein/galectin-10 interacts with cationic ribonucleases and is required for eosinophil granulogenesis.
Grozdanovic MM; Doyle CB; Liu L; Maybruck BT; Kwatia MA; Thiyagarajan N; Acharya KR; Ackerman SJ
J Allergy Clin Immunol; 2020 Aug; 146(2):377-389.e10. PubMed ID: 31982451
[TBL] [Abstract][Full Text] [Related]
19. Ultrastructural localization of Charcot-Leyden crystal protein (lysophospholipase) and peroxidase in macrophages, eosinophils, and extracellular matrix of the skin in the hypereosinophilic syndrome.
Dvorak AM; Weller PF; Monahan-Earley RA; Letourneau L; Ackerman SJ
Lab Invest; 1990 May; 62(5):590-607. PubMed ID: 2160562
[TBL] [Abstract][Full Text] [Related]
20. A Brief History of Charcot-Leyden Crystal Protein/Galectin-10 Research.
Su J
Molecules; 2018 Nov; 23(11):. PubMed ID: 30424011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
